An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

NGM Clinical Study Site, Los Angeles, California, United States

NGM Clinical Study Site, Los Angeles, California, United States

NGM Clinical Study Site, Santa Rosa, California, United States

NGM Clinical Study Site, Margate, Florida, United States

NGM Clinical Study Site, Baltimore, Maryland, United States

NGM Clinical Study Site, New York, New York, United States

NGM Clinical Study Site, Toledo, Ohio, United States

NGM Clinical Study Site, Youngstown, Ohio, United States

NGM Clinical Study Site, Dallas, Texas, United States

NGM Clinical Study Site, Kingwood, Texas, United States

NGM Clinical Study Site, Laredo, Texas, United States

NGM Clinical Study Site, Richmond, Virginia, United States

NGM Clinical Study Site, Appleton, Wisconsin, United States

NGM Clinical Study Site, Tbilisi, Georgia

NGM Clinical Study Site, Tbilisi, Georgia

NGM Clinical Study Site, Tbilisi, Georgia

NGM Clinical Study Site, Tbilisi, Georgia

NGM Clinical Study Site, Tbilisi, Georgia

NGM Clinical Study Site, Goyang, South Korea

NGM Clinical Study Site, Goyang, South Korea

NGM Clinical Study Site, Incheon, South Korea

NGM Clinical Study Site, Seoul, South Korea

NGM Clinical Study Site, Seoul, South Korea

NGM Clinical Study Site, Seoul, South Korea

NGM Clinical Study Site, Suwon, South Korea

NGM Clinical Study Site, Taichung, Taiwan

NGM Clinical Study Site, Taipei, Taiwan

NGM Clinical Study Site, Taoyuan, Taiwan